![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
2
*
Research Institute of Child Nutrition, Dortmund, Germany;
Institute of Nutrition, University of Giessen, Giessen, Germany; and
**
Max-Planck-Institute for Molecular Physiology, Dortmund, Germany
2To whom correspondence should be addressed.
In examining the functional aspects of human milk oligosaccharides (HMO), it is not known whether they are digested during the passage through the infant’s gastrointestinal tract. HMO were prepared from individual milk samples (n = 6) and separated into neutral and acidic compounds by chromatography. These oligosaccharide fractions were studied for their digestibility by human salivary amylase, porcine pancreatic amylase and brush border membrane vesicles (BBMV) isolated from porcine small intestine; we also examined the effect of low pH on these structures. The characterization of HMO and their digestion products was performed by high-pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) as well as TLC. It was shown that neither salivary amylase nor pancreatic amylase cleaved HMO. Only after a 2-h incubation with BBMV were slight modifications of the HMO observed. HPAEC-PAD analysis revealed two new components within the neutral oligosaccharide fractions; these were characterized by mass spectrometric analysis as lacto-N-triose and galactose. Only lacto-N-triose was present within digestion assays of oligosaccharides, which did not contain fucosyl or N-acetylneuraminic acid residues. These results suggest that <5% of the HMO are digested in the intestinal tract. Hence, HMO may play a role as prebiotics or as factors influencing the local immune system of the intestine in breast-fed infants.
KEY WORDS: • milk oligosaccharides • digestion • humans • brush border membrane vesicles
This article has been cited by other articles:
|
|
 |
|
  G. Boehm and G. Moro Structural and Functional Aspects of Prebiotics Used in Infant Nutrition J. Nutr., September 1, 2008; 138(9): 1818S - 1828S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M M Quigley Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy? J. Am. Coll. Nutr., December 1, 2007; 26(6): 684S - 690S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bode Recent Advances on Structure, Metabolism, and Function of Human Milk Oligosaccharides J. Nutr., August 1, 2006; 136(8): 2127 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Ward, M. Ninonuevo, D. A. Mills, C. B. Lebrilla, and J. B. German In Vitro Fermentation of Breast Milk Oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl. Envir. Microbiol., June 1, 2006; 72(6): 4497 - 4499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bode, S. Rudloff, C. Kunz, S. Strobel, and N. Klein Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil {beta} 2 integrin expression J. Leukoc. Biol., October 1, 2004; 76(4): 820 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Martin-Sosa, M.-J. Martin, L.-A. Garcia-Pardo, and P. Hueso Sialyloligosaccharides in Human and Bovine Milk and in Infant Formulas: Variations with the Progression of Lactation J Dairy Sci, January 1, 2003; 86(1): 52 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duggan, J. Gannon, and W A. Walker Protective nutrients and functional foods for the gastrointestinal tract Am. J. Clinical Nutrition, May 1, 2002; 75(5): 789 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gnoth, S. Rudloff, C. Kunz, and R. K. H. Kinne Investigations of the in Vitro Transport of Human Milk Oligosaccharides by a Caco-2 Monolayer Using a Novel High Performance Liquid Chromatography-Mass Spectrometry Technique J. Biol. Chem., September 7, 2001; 276(37): 34363 - 34370. [Abstract] [Full Text] [PDF]
|
|
